4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0001578563-25-000198
Chief Financial Officer gave up 7,285 shares (to pay taxes)
- Chief Financial Officer acquired 24,200 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Sullivan Christopher Ryan · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-03-28 | Exercise or conversion : show line 1 in the form | +24,200 | 24,206 | D | ||
| 2025-03-28 | Shares withheld for taxes : show line 2 in the form | −7,285 | $8.46 | $61,631 | 16,921 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-03-28 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −24,200 | 48,400 | D |
Loading xslF345X05/primary_doc.xml…